share_log

東瑞製葯:2023中期報告

DAWNRAYS PHARMA: 2023 INTERIM REPORT

香港交易所 ·  Sep 13, 2023 04:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more